Biocom Appoints New Members to Its Board of Directors [Yahoo! Finance]
Neurocrine Biosciences, Inc. (NBIX)
Last neurocrine biosciences, inc. earnings: 2/4 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
neurocrine.com/about-us/webcasts-presentations
Company Research
Source: Yahoo! Finance
companies across California and major life science markets, today announced the appointment of Aaron K. Cohen, vice president, government affairs and public policy at Neurocrine Biosciences and Bradley Wolff, senior managing director at Evercore, to its board of directors. "Mr. Cohen and Mr. Wolff are valuable additions to our board of directors, which consists of prominent life science leaders with deep industry knowledge representing regions across the state," said Tim Scott, president and CEO of Biocom. "As the life science industry evolves, we rely on the expertise and insight from our board to ensure we continue to equip member companies with vital resources as well as advance key initiatives that foster growth and innovation." Aaron K. Cohen leads federal and state government affairs and public policy teams as the head of Neurocrine Biosciences' Washington, D.C. office. He has over 25 years of experience in public policy and political strategy on Capitol Hill and in the priv
Show less
Read more
Impact Snapshot
Event Time:
NBIX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NBIX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NBIX alerts
High impacting Neurocrine Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
NBIX
News
- Neurocrine Biosciences Appoints Andrew Ratz, Ph.D., as Chief Technical Operations Officer [Yahoo! Finance]Yahoo! Finance
- Neurocrine Biosciences Appoints Andrew Ratz, Ph.D., as Chief Technical Operations OfficerPR Newswire
- Neurocrine Biosciences: The Song Remains The Same [Seeking Alpha]Seeking Alpha
- Neurocrine Biosciences (NBIX) had its price target raised by JPMorgan Chase & Co. from $176.00 to $177.00. They now have an "overweight" rating on the stock.MarketBeat
- Neurocrine Biosciences to Present at the Stifel 2026 Virtual CNS ForumPR Newswire
NBIX
Earnings
- 2/11/26 - Beat
NBIX
Sec Filings
- 3/17/26 - Form 3
- 3/5/26 - Form 4
- 2/23/26 - Form 4
- NBIX's page on the SEC website